Balancing The Scales: The Ups And Downs Of Bioprocess Scale-Up
Dry Powder Inhalable Vaccines For Shelf Stability And Global Access
Navigating Your Holistic Approach To CCI For Biologic Drug Products
Accelerating Drug Development: Flexible And Fast DNA-To-IND Programs
Leveraging Platforms To Create Vaccines At Pandemic Speed
Analytical Strategies To Address Common Development Challenges
Harnessing New Tech To Create Next-Generation GS-CHO Expression Solutions
Embrace Molecule Complexity With Optimized Expression Technologies
Challenges Of Moving A Bioconjugate Candidate From Clinic To Market
Tailored CMC Solutions That Meet Needs Of Novel Molecular Biologic Formats
DNA To IND In 11 Months: Integrated Drug Substance, Drug Product Offering
Early Development To Clinic – De-Risking A Bioconjugate's Journey
Challenges Associated With In-Use Simulated Administration Of Biologics
Development, Manufacture Of Biopharmaceuticals In Microbial Systems
Our Biotech Success — Surrozen
Pionyr: Selecting A CDMO To Scale-Up Manufacturing
Addressing Key Challenges Of High Concentration Formulation Development
How To Bring (Any) mRNA To Life: Simplifying Nucleic Acid Encapsulation
Identifying And Mitigating Potential For Immunogenicity, Immunotoxicity
Expressing Next-Gen Immunotherapies And Other Advanced Biologics
Developing A mAb For A Small Biotech Developing Precision Medicines
Reaching BLA Success: Fast-Track Approach To Process Characterization
Hybrid Approach For Optimizing Transient Protein Expression In CHO Cells
Predictive Modeling Of Concentration-Dependent Viscosity Behavior
Optimizing The Path To First-In-Human Clinical Trials: Design And De-Risk
Deciphering mRNA Immunogenicity: Early Assessment Of Human Immune Response
Overcome Manufacturability, Expression, Early Material Generation Challenges
Trends, Challenges, And Opportunities In Bispecific Antibodies
Particle Investigation: Going One Step Further Than Just The Identification
In Silico, In Vitro Tools For Regulatory Submission, Feedback
Drug Product Process Characterization For Liquid And Lyophilized DP
Our Biotech Success — Levicept
Inclusion Bodies: Mother Nature's Help Or Hindrance?
Mitigate Risk Of Failure In Biotherapeutic Development
Scalable Protein Expression With Pichia Pastoris
Filling The Need For Integrated Bioconjugate Solutions
Precision Execution Of Bispecifics At Scale From Design To Delivery
Effective Technology Transfer For Mammalian Derived Biopharmaceuticals
Overcoming The Challenges In Fabs And Fc-Fusion Development Programs
Achieving Biologics License Application Success Using A Structured Approach
Early Developability And Analytical Toolbox For The Production Of Multi-Chain Biotherapeutics
CMC Strategy To Take Bispecifics From DNA To IND In 13 Months
Key Enablers For Late Phase Biologic Drug Development, Launch
Best Tech Transfer Practices To Optimize Clinical And Commercial Supply
Process Intensification To Improve Efficiency, Productivity
Increase Spray Drying Throughput For Brick Dust Compounds
Pharmaceutical Spray Drying: Sustainable Commercial Best Practices
PBPK Modeling: Mitigating Absorption Risks In Early Drug Development
Process Re-Design For Sustainability In Small Molecule Manufacturing
Streamlined Selection Of In Vivo Predictive Dissolution Media
Identify And Mitigate Absorption Risks With PBPK Modeling
How To Design An HPAPI Plant And Its Containment Systems
Local Delivery For Treatment Of Lung Cancer
Chromatography, Purification & Isolation Technologies
Simultaneous Spray Drying: Dry Powder Inhaler Combination Formulations
Particle Size Control Through Micronization: Challenges And Solutions
Environmental Sustainability: Wastewater Incineration Reduction
How To Deal With The Complexity Of Drugs In Clinical Development
Meeting The Challenge Of Rising API Complexity
Continuous Flow Techniques For Fine Chemical Manufacturing
Environmental Sustainability: Use Case - Solvent Recovery
How To Safely Handle Your Antibody Drug Conjugate
From Powder To Particles With Jet Milling
Rapid, Material-Sparing Feasibility Screening For Hot Melt Extrusion
Rapid Development Of Amorphous Solid Dispersions For Bioavailability
Solid Form Screening Of Active Pharmaceutical Ingredients
Dramatic Reduction Of Solvent Usage In Pharmaceutical Spray Drying
Path To IND: AAV Transient Transfection, Producer Cell Line Platforms
Keys To A Successful cGMP Manufacturing Operation Delivering CGTs
Improved And Rebalanced Plasmids To Ramp Up Your AAV Productivity
The CDMO Value Proposition For Your Autologous Cell Therapy
